Zoar Limited Completes Business Combination and NYSE Listing

Health

Merger / DESPAC
IPO:
Nov 18, 2026
Industry:
PHARMACEUTICAL PREPARATIONS
Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Zoar Limited Completes Business Combination with Impact Biomedical Inc.
Hong Kong, November 18, 2026 -- Zoar Limited (NYSE American: ZOAR) announced the completion of its business combination with Impact Biomedical Inc., Dr Ashleys Nevada Sub Inc., and Zoar Labs Limited. The company's ordinary shares are expected to begin trading on the NYSE American under the ticker symbol ZOAR.
... Read on — Members only
About Zoar Ltd
Zoar Limited is a global pharmaceutical company focused on the development and manufacturing of active pharmaceutical ingredients and orphan drugs and provides contract development and manufacturing services to pharmaceutical and biotechnology companies worldwide. To date, Zoar Limited has shipped more than 85 pharmaceutical products to customers in 35 countries.





















